Skip to main content
Erschienen in: Pathology & Oncology Research 3/2018

27.07.2017 | Original Article

High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting

verfasst von: Tihana Džombeta, Božo Krušlin

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Differentiation of noninvasive from invasive papillary urothelial carcinoma can be challenging due to inability of proper orientation and thermal damage of transurethrally obtained material. The aim of this study was to analyze the presence and extent of peritumoral retractions in pT1 compared to pTa papillary urothelial carcinoma. Since peritumoral retractions may result from altered expression profiles of extracellular matrix proteins, we additionally analyzed the expression of matrix metalloproteinase 2 (MMP-2) and interleukin 8 (IL-8) in these tumors. The study comprised 50 noninvasive (pTa) and 50 invasive (pT1) cases of transurethrally obtained primary papillary urothelial carcinomas. The invasive nature of nests showing peritumoral retractions was confirmed immunohistochemically using antibody against collagen IV. Staining for MMP-2 and IL-8 was evaluated semiquantitatively using immunohistochemical staining index, calculated by multiplying the percentage of positive cells and staining intensity. Peritumoral retractions were found in 32% of pT1 carcinomas but in none of the pTa carcinomas. All tumors showing peritumoral retraction were high grade tumors. There was no statistically significant correlation between the expression of MMP-2 or IL-8 and the presence of peritumoral retractions or stage of the tumor (pTa vs. pT1). A statistically significant but weak correlation was found between MMP-2 and IL-8 expression (χ2-test, p=0,015). There was no statistically significant correlation between the presence of peritumoral retractions or MMP-2 expression and tumor recurrence and progression. Our study shows that, in doubtful cases, when differentiating between pTa and pT1 stages of papillary urothelial carcinoma, the presence of peritumoral retractions could favor the diagnosis of invasive neoplasm.
Literatur
1.
Zurück zum Zitat Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, Kruck S, Stenzl A (2009) Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27:295–300CrossRefPubMedPubMedCentral Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, Kruck S, Stenzl A (2009) Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27:295–300CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Tumours of the Urinary System (2004) In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of Tumours: pathology and genetics of Tumours of the urinary system and male genital organs, 3rd edn. IARC Press, Lyon, pp 90–123 Tumours of the Urinary System (2004) In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of Tumours: pathology and genetics of Tumours of the urinary system and male genital organs, 3rd edn. IARC Press, Lyon, pp 90–123
3.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (2010) International union against cancer. TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Chichester Sobin LH, Gospodarowicz MK, Wittekind C (2010) International union against cancer. TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Chichester
4.
Zurück zum Zitat Cheng L, Lopez-Beltran A, MacLennan GT, Montironi R, Bostwick DG (2014) Neoplasms of the urinary bladder. In: Bostwick DG, Cheng (eds) urologic surgical pathology, 3rd edn. Elsevier Saunders, Philadelphia, pp 243–268 Cheng L, Lopez-Beltran A, MacLennan GT, Montironi R, Bostwick DG (2014) Neoplasms of the urinary bladder. In: Bostwick DG, Cheng (eds) urologic surgical pathology, 3rd edn. Elsevier Saunders, Philadelphia, pp 243–268
5.
Zurück zum Zitat Kruslin B, Tomas D, Rogatsch H, Novosel I, Cupić H, Belicza M, Kraus O, Mikuz G (2003) Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact? Virchows Arch 443:524–527CrossRefPubMed Kruslin B, Tomas D, Rogatsch H, Novosel I, Cupić H, Belicza M, Kraus O, Mikuz G (2003) Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact? Virchows Arch 443:524–527CrossRefPubMed
6.
7.
Zurück zum Zitat Tomas D, Spajić B, Milošević M, Demirović A, Marušić Z, Krušlin B (2011) Extensive retraction artifacts predict biochemical recurrence-free survival in prostatic carcinoma. Histopathology 58:447–454CrossRefPubMed Tomas D, Spajić B, Milošević M, Demirović A, Marušić Z, Krušlin B (2011) Extensive retraction artifacts predict biochemical recurrence-free survival in prostatic carcinoma. Histopathology 58:447–454CrossRefPubMed
8.
Zurück zum Zitat Acs G, Dumoff KL, Solin LJ, Pasha T, Xu X, Zhang PJ (2007) Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma. Am J Surg Pathol 31:129–140CrossRefPubMed Acs G, Dumoff KL, Solin LJ, Pasha T, Xu X, Zhang PJ (2007) Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma. Am J Surg Pathol 31:129–140CrossRefPubMed
9.
Zurück zum Zitat Larsen MP, Steinberg GD, Brendler CB, Epstein JI (1990) Use of Ulex Europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 3:83–88PubMed Larsen MP, Steinberg GD, Brendler CB, Epstein JI (1990) Use of Ulex Europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 3:83–88PubMed
10.
Zurück zum Zitat Ramani P, Birch BR, Harland SJ, Parkinson MC (1991) Evaluation of endothelial markers in detecting blood and lymphatic channel invasion in pT1 transitional carcinoma of bladder. Histopathology 19:551–554CrossRefPubMed Ramani P, Birch BR, Harland SJ, Parkinson MC (1991) Evaluation of endothelial markers in detecting blood and lymphatic channel invasion in pT1 transitional carcinoma of bladder. Histopathology 19:551–554CrossRefPubMed
11.
Zurück zum Zitat Sangoi AR, Higgins JP, Rouse RV, Schneider AG, McKenney JK (2009) Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact. Mod Pathol 22:660–667CrossRefPubMed Sangoi AR, Higgins JP, Rouse RV, Schneider AG, McKenney JK (2009) Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact. Mod Pathol 22:660–667CrossRefPubMed
13.
Zurück zum Zitat Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448–464CrossRefPubMed Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448–464CrossRefPubMed
14.
Zurück zum Zitat Wallard MJ, Pennington CJ, Veerakumarasivam A, Burtt G, Mills IG, Warren A, Leung HY, Murphy G, Edwards DR, Neal DE, Kelly JD (2006) Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer 94:569–577CrossRefPubMedPubMedCentral Wallard MJ, Pennington CJ, Veerakumarasivam A, Burtt G, Mills IG, Warren A, Leung HY, Murphy G, Edwards DR, Neal DE, Kelly JD (2006) Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer 94:569–577CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85 Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85
16.
Zurück zum Zitat Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376 Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376
17.
Zurück zum Zitat Urquidi V, Chang M, Dai Y, Kim J, Wolfson ED, Goodison S, Rosser CJ (2012) IL-8 as a urinary biomarker for the detection of bladder cancer. BMC Urol 12:12CrossRefPubMedPubMedCentral Urquidi V, Chang M, Dai Y, Kim J, Wolfson ED, Goodison S, Rosser CJ (2012) IL-8 as a urinary biomarker for the detection of bladder cancer. BMC Urol 12:12CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Rosser CJ, Chang M, Dai Y, Ross S, Mengual L, Alcaraz A, Goodison S (2014) Urinary protein biomarker panel for the detection of recurrent bladder cancer. Cancer Epidemiol Biomark Prev 23:1340–1345CrossRef Rosser CJ, Chang M, Dai Y, Ross S, Mengual L, Alcaraz A, Goodison S (2014) Urinary protein biomarker panel for the detection of recurrent bladder cancer. Cancer Epidemiol Biomark Prev 23:1340–1345CrossRef
19.
Zurück zum Zitat Tumours of the Urinary System (2016) In: Moch H, Humphrey PA, Ulbright TM, Reuter VE (eds) World Health Organization classification of Tumours: pathology and genetics of Tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon, pp 78–108 Tumours of the Urinary System (2016) In: Moch H, Humphrey PA, Ulbright TM, Reuter VE (eds) World Health Organization classification of Tumours: pathology and genetics of Tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon, pp 78–108
20.
Zurück zum Zitat Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM (2015) Clinical outcomes of cT1 micropapillary bladder cancer. J Urol 193:1129–1134CrossRefPubMed Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM (2015) Clinical outcomes of cT1 micropapillary bladder cancer. J Urol 193:1129–1134CrossRefPubMed
21.
Zurück zum Zitat Krušlin B, Tomas D, Cviko A, Čupić H, Odak L, Belicza M (2006) Periacinar Clefting and p63 immunostaining in prostatic intraepithelial neoplasia and prostatic carcinoma. Pathol Oncol Res 12:205–209CrossRefPubMed Krušlin B, Tomas D, Cviko A, Čupić H, Odak L, Belicza M (2006) Periacinar Clefting and p63 immunostaining in prostatic intraepithelial neoplasia and prostatic carcinoma. Pathol Oncol Res 12:205–209CrossRefPubMed
22.
Zurück zum Zitat McKenney JK, Gomez JA, Desai S, Lee MW, Amin MB (2001) Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 25:356–362CrossRefPubMed McKenney JK, Gomez JA, Desai S, Lee MW, Amin MB (2001) Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 25:356–362CrossRefPubMed
24.
Zurück zum Zitat Cardiff RD, Borowsky AD (2010) Precancer: sequentially acquired or predetermined? Toxicol Pathol 38:171–179CrossRefPubMed Cardiff RD, Borowsky AD (2010) Precancer: sequentially acquired or predetermined? Toxicol Pathol 38:171–179CrossRefPubMed
25.
Zurück zum Zitat van der Horst G, Bos L, van der Pluijm G (2012) Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. Mol Cancer Res 10:995–1009CrossRefPubMed van der Horst G, Bos L, van der Pluijm G (2012) Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. Mol Cancer Res 10:995–1009CrossRefPubMed
26.
Zurück zum Zitat Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66:11271–11278CrossRefPubMed Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66:11271–11278CrossRefPubMed
27.
Zurück zum Zitat Tomas D, Ulamec M, Hudolin T, Bulimbašić S, Belicza M, Krušlin B (2006) Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate cancer. Prostate Cancer Prostatic Dis 9:414–419CrossRefPubMed Tomas D, Ulamec M, Hudolin T, Bulimbašić S, Belicza M, Krušlin B (2006) Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate cancer. Prostate Cancer Prostatic Dis 9:414–419CrossRefPubMed
28.
Zurück zum Zitat Fávaro WJ, Hetzl AC, Reis LO, Ferreira U, Billis A, Cagnon VH (2012) Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement. Pathol Oncol Res 18:285–292CrossRefPubMed Fávaro WJ, Hetzl AC, Reis LO, Ferreira U, Billis A, Cagnon VH (2012) Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement. Pathol Oncol Res 18:285–292CrossRefPubMed
29.
Zurück zum Zitat Acs G, Khakpour N, Kiluk J, Lee MC, Laronga C (2015) The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases. Am J Surg Pathol 39:325–337CrossRefPubMed Acs G, Khakpour N, Kiluk J, Lee MC, Laronga C (2015) The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases. Am J Surg Pathol 39:325–337CrossRefPubMed
30.
Zurück zum Zitat Hadler-Olsen E, Winberg JO, Uhlin-Hansen L (2013) Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 34:2041–2051CrossRefPubMed Hadler-Olsen E, Winberg JO, Uhlin-Hansen L (2013) Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 34:2041–2051CrossRefPubMed
31.
Zurück zum Zitat Eissa S, Ali-Labib R, Swellam M, Bassiony M, Tash F, El-Zayat TM (2007) Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol 52:1388–1396CrossRefPubMed Eissa S, Ali-Labib R, Swellam M, Bassiony M, Tash F, El-Zayat TM (2007) Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol 52:1388–1396CrossRefPubMed
32.
Zurück zum Zitat Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA (2008) Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res 14:6610–6617CrossRefPubMedPubMedCentral Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA (2008) Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res 14:6610–6617CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365–5369PubMed Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365–5369PubMed
34.
Zurück zum Zitat Vasala K, Pääkkö P, Turpeenniemi-Hujanen T (2003) Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. Urology 62:952–957CrossRefPubMed Vasala K, Pääkkö P, Turpeenniemi-Hujanen T (2003) Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. Urology 62:952–957CrossRefPubMed
35.
Zurück zum Zitat Szarvas T, Becker M, Vom Dorp F, Gethmann C, Tötsch M, Bánkfalvi A, Schmid KW, Romics I, Rübben H, Ergün S (2010) Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer. Cancer Sci 101:1300–1308CrossRefPubMed Szarvas T, Becker M, Vom Dorp F, Gethmann C, Tötsch M, Bánkfalvi A, Schmid KW, Romics I, Rübben H, Ergün S (2010) Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer. Cancer Sci 101:1300–1308CrossRefPubMed
36.
Zurück zum Zitat Szarvas T, Jäger T, Becker M, Tschirdewahn S, Niedworok C, Kovalszky I, Rübben H, Ergün S, Vom Dorp F (2011) Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer. Pathol Oncol Res 17:325–332CrossRefPubMed Szarvas T, Jäger T, Becker M, Tschirdewahn S, Niedworok C, Kovalszky I, Rübben H, Ergün S, Vom Dorp F (2011) Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer. Pathol Oncol Res 17:325–332CrossRefPubMed
37.
Zurück zum Zitat Reis ST, Leite KR, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP, Srougi M, Dall’Oglio MF (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder cancer. BMC Urol 12:18 Reis ST, Leite KR, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP, Srougi M, Dall’Oglio MF (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder cancer. BMC Urol 12:18
38.
Zurück zum Zitat Xia W, Chen W, Zhang Z, Wu D, Wu P, Chen Z, Li C, Huang J (2015) Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis. PLoS One 10:e0123484CrossRefPubMedPubMedCentral Xia W, Chen W, Zhang Z, Wu D, Wu P, Chen Z, Li C, Huang J (2015) Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis. PLoS One 10:e0123484CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Zhang G, Gomes-Giacoia E, Dai Y, Lawton A, Miyake M, Furuya H, Goodison S, Rosser CJ (2014) Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature. Diagn Pathol 9:200CrossRefPubMedPubMedCentral Zhang G, Gomes-Giacoia E, Dai Y, Lawton A, Miyake M, Furuya H, Goodison S, Rosser CJ (2014) Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature. Diagn Pathol 9:200CrossRefPubMedPubMedCentral
Metadaten
Titel
High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting
verfasst von
Tihana Džombeta
Božo Krušlin
Publikationsdatum
27.07.2017
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2018
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-017-0279-2

Weitere Artikel der Ausgabe 3/2018

Pathology & Oncology Research 3/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.